Thyroid (USP) 90 MG Oral Tablet [NP Thyroid] — RxCUI 1724437
RxNorm drug concept · Semantic branded drug
RxCUI 1724437
Semantic branded drug · SBD
● Current RxNorm concept 10 FDA products
26 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1724437
Official nameThyroid (USP) 90 MG Oral Tablet [NP Thyroid]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asNP Thyroid 90 MG Oral Tablet; NP Thyroid (levothyroxine sodium 57 MCG / liothyronine sodium 13.5 MCG) Oral Tablet; NP Thyroid 1 1/2 grain Oral Tablet
FDA products mapped10
Package NDCs mapped26
Reported Medicaid activity (SDUD)83,543 prescriptions · 48 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Thyroid: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Great question. Desiccated thyroid — the active ingredient in products like Amerithroid and Thyroid Tablets — is made from dried pig (porcine) thyroid glands. It naturally contains...
- What exactly is desiccated thyroid, and is it different from the synthetic thyroid hormone my friend takes?
- It does matter a bit. Fasting actually increases the absorption of thyroid hormones, so many people take their tablet first thing in the morning, about 30–60 minutes before eating....
- Can I take my thyroid tablet with breakfast, or does it matter?
🕸️ Concept Web — How Thyroid (USP) 90 MG Oral Tablet [NP Thyroid] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Thyroid (USP) 90 MG Oral Tablet [NP Thyroid]
RxCUI 1724437 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Thyroid (USP)
10572IN
-
Thyroid (USP)
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
NP Thyroid
1724432BN
-
NP Thyroid
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Thyroid (USP) Oral Tablet
374122SCDF -
Thyroid (USP) Oral Product
1162082SCDG -
Thyroid (USP) Pill
1162083SCDG -
Thyroid (USP) Oral Tablet [NP Thyroid]
1724434SBDF -
NP Thyroid Oral Product
1724435SBDG -
NP Thyroid Pill
1724436SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Thyroid (USP) Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Thyroid (USP) 90 MG Oral Tablet
313393SCD -
Thyroid (USP) 90 MG
331520SCDC -
Thyroid (USP) 90 MG [NP Thyroid]
1724433SBDC
-
Thyroid (USP) 90 MG Oral Tablet
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Thyroid (USP) 90 MG Oral Tablet
SCD · 313393 -
Thyroid (USP) 90 MG
SCDC · 331520 -
Thyroid (USP) Oral Tablet
SCDF · 374122 -
Thyroid (USP) Oral Product
SCDG · 1162082 -
Thyroid (USP) Pill
SCDG · 1162083
Brand-Name Concepts
-
Thyroid (USP) 90 MG [NP Thyroid]
SBDC · 1724433 -
Thyroid (USP) Oral Tablet [NP Thyroid]
SBDF · 1724434 -
NP Thyroid Oral Product
SBDG · 1724435 -
NP Thyroid Pill
SBDG · 1724436 -
NP Thyroid
BN · 1724432
📦 FDA Products & Package NDCs
10 products · 26 package NDCs
26 package NDCs map to RxCUI 1724437 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 17224-0504-28 | 28 TABLET in 1 BOTTLE (17224-504-28) | NP Thyroid | Calvin Scott & Co Inc. | 2025-08-01 |
| 17224-0504-30 | 30 TABLET in 1 BOTTLE (17224-504-30) | NP Thyroid | Calvin Scott & Co Inc. | 2025-08-01 |
| 17224-0504-60 | 60 TABLET in 1 BOTTLE (17224-504-60) | NP Thyroid | Calvin Scott & Co Inc. | 2025-08-01 |
| 42192-0327-01 | 100 TABLET in 1 BOTTLE (42192-327-01) | NP Thyroid 15 | Acella Pharmaceuticals, LLC | 2016-11-16 |
| 42192-0327-30 | 30 TABLET in 1 BOTTLE (42192-327-30) | NP Thyroid 15 | Acella Pharmaceuticals, LLC | 2025-03-03 |
| 42192-0327-90 | 90 TABLET in 1 BOTTLE (42192-327-90) | NP Thyroid 15 | Acella Pharmaceuticals, LLC | 2025-12-01 |
| 42192-0328-01 | 100 TABLET in 1 BOTTLE (42192-328-01) | NP Thyroid 120 | Acella Pharmaceuticals, LLC | 2017-06-12 |
| 42192-0328-30 | 30 TABLET in 1 BOTTLE (42192-328-30) | NP Thyroid 120 | Acella Pharmaceuticals, LLC | 2025-03-03 |
| 42192-0328-90 | 90 TABLET in 1 BOTTLE (42192-328-90) | NP Thyroid 120 | Acella Pharmaceuticals, LLC | 2025-12-01 |
| 42192-0329-01 | 100 TABLET in 1 BOTTLE (42192-329-01) | NP Thyroid 30 | Acella Pharmaceuticals, LLC | 2011-01-14 |
| 42192-0329-10 | 1000 TABLET in 1 BOTTLE (42192-329-10) | NP Thyroid 30 | Acella Pharmaceuticals, LLC | 2025-03-03 |
| 42192-0329-30 | 30 TABLET in 1 BOTTLE (42192-329-30) | NP Thyroid 30 | Acella Pharmaceuticals, LLC | 2025-03-03 |
| 42192-0329-90 | 90 TABLET in 1 BOTTLE (42192-329-90) | NP Thyroid 30 | Acella Pharmaceuticals, LLC | 2025-12-01 |
| 42192-0330-01 | 100 TABLET in 1 BOTTLE (42192-330-01) | NP Thyroid 60 | Acella Pharmaceuticals, LLC | 2010-11-11 |
| 42192-0330-10 | 1000 TABLET in 1 BOTTLE (42192-330-10) | NP Thyroid 60 | Acella Pharmaceuticals, LLC | 2025-03-03 |
| 42192-0330-30 | 30 TABLET in 1 BOTTLE (42192-330-30) | NP Thyroid 60 | Acella Pharmaceuticals, LLC | 2025-03-03 |
| 42192-0330-90 | 90 TABLET in 1 BOTTLE (42192-330-90) | NP Thyroid 60 | Acella Pharmaceuticals, LLC | 2025-12-01 |
| 42192-0331-01 | 100 TABLET in 1 BOTTLE (42192-331-01) | NP Thyroid 90 | Acella Pharmaceuticals, LLC | 2011-02-03 |
| 42192-0331-10 | 1000 TABLET in 1 BOTTLE (42192-331-10) | NP Thyroid 90 | Acella Pharmaceuticals, LLC | 2025-03-03 |
| 42192-0331-30 | 30 TABLET in 1 BOTTLE (42192-331-30) | NP Thyroid 90 | Acella Pharmaceuticals, LLC | 2025-03-03 |
| 42192-0331-90 | 90 TABLET in 1 BOTTLE (42192-331-90) | NP Thyroid 90 | Acella Pharmaceuticals, LLC | 2025-12-01 |
| 50090-5229-00 | 90 TABLET in 1 BOTTLE (50090-5229-0) | NP THYROID 90 | A-S Medication Solutions | 2020-10-08 |
| 76420-0569-01 | 100 TABLET in 1 BOTTLE (76420-569-01) | NP Thyroid 90 | Asclemed USA, Inc. | 2023-05-16 |
| 76420-0569-30 | 30 TABLET in 1 BOTTLE (76420-569-30) | NP Thyroid 90 | Asclemed USA, Inc. | 2023-05-16 |
| 76420-0569-60 | 60 TABLET in 1 BOTTLE (76420-569-60) | NP Thyroid 90 | Asclemed USA, Inc. | 2023-05-16 |
| 76420-0569-90 | 90 TABLET in 1 BOTTLE (76420-569-90) | NP Thyroid 90 | Asclemed USA, Inc. | 2023-05-16 |
Observed labelers:
Acella Pharmaceuticals, LLC (18) ·
Asclemed USA, Inc. (4) ·
Calvin Scott & Co Inc. (3) ·
A-S Medication Solutions (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.